parthenolide has been researched along with Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X; Liu, G; Liu, J; Miao, L; Peng, Q; Song, W; Yang, B; Zhang, P; Zhang, Y | 1 |
| Cui, L; Dong, L; Li, Y; Liu, Z; Qiao, H; Wang, C; Wang, L; Xing, Y; Zhang, X; Zhao, J; Zhu, C | 1 |
2 other study(ies) available for parthenolide and Stroke
| Article | Year |
|---|---|
Parthenolide modulates cerebral ischemia-induced microglial polarization and alleviates neuroinflammatory injury via the RhoA/ROCK pathway.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cerebral Infarction; Humans; Microglia; Rats; rhoA GTP-Binding Protein; Sesquiterpenes; Stroke | 2022 |
Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Caspase 1; Claudin-5; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Permeability; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Stroke | 2013 |